This device has been used extensively in literature, usually at a dose to of 20IU or 40IU of insulin, and has been shown to elicit beneficial effects on various endpoints, both in healthy persons and patients with Alzheimer's disease [25, 26]. Here, INS is linked to Alzheimer disease.